// App-Quantinova.ai

EP295 : Pre-operative full blood count, C-reactive protein and serum inflammation-based scores may predict aggressive or refractory disease in patients with pituitary adenomas

Researchers

Presenter

  • Pedro Marques

Principal Investigators

  • Friso de Vries

  • Wouter van Furth

  • Marta Korbonits

  • Nienke Biermasz

  • Alberto M Pereira

Medical Centers

  • Leiden University Medical Center, Leiden, The Netherlands, Center for Endocrine Tumors Leiden (CETL), Leiden, Netherlands

  • William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Centre for Experimental Medicine & Rheumatology, London, United Kingdom

Locations

  • Netherlands

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Systemic inflammation

  • Pituitary adenomas

  • Cushing's syndrome

  • Prolactin-secreting pituitary adenoma

  • Acromegaly

Biomarkers

  • Neutrophil lymphocyte ratio

  • C reactive protein

  • Perineural invasion

  • Platelet-lymphocyte ratio

  • Glasgow prognostic score

  • Human albumin

  • X-Ray Repair Cross Complementing 1

Drug/Treatment

  • Glucocorticoid

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved